A consumer electronics company distributes its products through authorised retailers across Europe. One morning, it discovers that a Dublin-based importer is selling the same branded goods – sourced from outside the European Economic Area – at prices that undercut its entire distribution network. The products are genuine. The packaging is intact. Yet the rights holder believes, with good reason, that something legally significant has occurred. Whether that belief translates into an enforceable claim depends almost entirely on where those goods were first placed on the market, and what body of law governs the answer.
Parallel import and IP rights exhaustion in Ireland are governed primarily by EU-derived intellectual property legislation, applied through Irish courts with reference to the doctrine of regional exhaustion. Under that doctrine, placing goods on the market within the European Economic Area with the rights holder's consent exhausts certain IP rights. However. Placing goods on a market outside the EEA does not exhaust rights in Ireland. The applicable rules differ across trademark, copyright, and patent rights, and the practical outcome of any dispute depends heavily on the consent analysis and the specific rights in question.
This analysis examines the doctrinal architecture of rights exhaustion in Ireland, the tensions between statute and judicial practice, the cross-border implications for businesses operating between Ireland and the broader EU single market. Strategic positions available to rights holders and importers. Additionally, the regulatory trajectory that will shape this area over the coming years.
Doctrinal foundations: regional exhaustion and the Irish legal position
The exhaustion doctrine rests on a fundamental tension. Intellectual property rights, by their nature, are territorial. A trademark registered in Ireland gives its owner control over use of the mark in Ireland. Yet enforcing that control to block the resale of genuinely marked goods. goods the rights holder itself placed into circulation. risks fragmenting markets and creating barriers to trade that EU law is designed to prevent.
Irish intellectual property legislation, implementing the relevant EU directives, resolves this tension through the principle of regional exhaustion. Once a rights holder – or a party with the rights holder's consent – places goods bearing a protected mark. Alternatively, goods embodying a protected design or invention. Onto the market within the European Economic Area, the rights holder loses the ability to rely on IP rights to prevent further distribution of those specific goods within the EEA. The rights are said to be exhausted.
The critical boundary is the EEA perimeter. Goods placed on markets in North America, Asia, or any territory outside the EEA have not triggered exhaustion under Irish or EU law. A rights holder can therefore invoke Irish IP protection to prevent those goods from being imported into Ireland. This is the core of what practitioners call the parallel import problem: the goods are genuine, but their market history places them in a legally distinct category.
Ireland's position as a common law jurisdiction within the EU adds a layer of interpretive texture. Irish courts approach statutory IP provisions through the lens of EU case law from the Court of Justice of the European Union. However. They also draw on domestic contract and tort principles when analysing consent and authorisation. This dual methodology creates some divergence from the approach taken by civil law courts elsewhere in Europe, even when interpreting identical legislative language.
For trademark rights specifically, Irish trademark legislation. implementing the EU Trade Marks Directive. preserves the rights holder's ability to oppose further commercialisation of goods even where EEA exhaustion has occurred. Provided the rights holder can demonstrate legitimate reasons. Courts in Ireland have interpreted this legitimate reasons exception with reference to CJEU guidance: the exception covers situations where the goods have been altered or impaired after initial marketing. Alternatively. There. Repackaging damages the trademark's reputation or function. The exception is not a broad residual discretion; Irish courts apply it narrowly and require concrete evidence of harm or impairment.
Consent, authorisation, and the gap between statute and practice
The exhaustion doctrine's pivot point is consent. Rights are exhausted only when the rights holder – or an entity economically linked to the rights holder – places goods on the market with the rights holder's authorisation. This sounds straightforward. In practice, it generates the most contested litigation in parallel import disputes.
Irish courts have addressed the consent question in several ways. Where goods are sold by a wholly-owned subsidiary or an exclusive licensee, consent is relatively easy to establish. The harder cases involve distribution arrangements that cross multiple tiers: a manufacturer sells to a regional distributor under a contract that restricts territory. The distributor resells to a sub-distributor in breach of contract. Additionally, the goods eventually enter Ireland. Has the manufacturer consented to EEA placement?
The CJEU has held that consent must be expressed unambiguously and cannot be implied merely from the rights holder's silence or failure to prevent distribution. Irish courts follow this position. A manufacturer's contractual restriction on territory is evidence against consent. However, it is not conclusive. Because the restriction speaks to the contract between manufacturer and distributor. it does not automatically determine whether the manufacturer has, as a matter of IP law, consented to EEA market placement.
Practitioners in Ireland note a recurring gap between what distributors believe they are entitled to do under their supply contracts and what the IP legislation actually permits. A distributor authorised to sell in Germany may assume that goods purchased from the German subsidiary can be freely circulated anywhere within the EEA. That assumption is often correct as a matter of EU free movement law. It is not always correct as a matter of contract, and it may not be correct if the goods originated outside the EEA and were merely transshipped through Germany.
The provenance tracing exercise that this requires – establishing a complete chain of market placement from manufacturer to final sale – is demanding in practice. Rights holders frequently struggle to obtain disclosure of the full supply chain. Irish procedural rules give courts the power to order disclosure, but obtaining meaningful information from overseas entities often requires coordinating with foreign courts or relying on contractual audit rights that may themselves be contested.
Copyright exhaustion presents a distinct profile. Under Irish copyright legislation implementing the EU Copyright Directive, the distribution right in a physical copy of a copyrighted work is exhausted once the copy is sold within the EEA with the rights holder's consent. Digital transmissions are treated differently: the CJEU has held that exhaustion does not apply to digital downloads in the same way it applies to physical copies. For businesses dealing in software, e-books, or digital media, the line between physical and digital distribution has significant commercial consequences in the Irish market.
Patent rights in Ireland follow the same regional exhaustion model. Once a patented product is placed on the EEA market by or with the consent of the patent holder, the patent holder cannot rely on the Irish patent to block further distribution within the EEA. Pharmaceuticals represent the most commercially significant application of this principle. Parallel trade in medicinal products authorised in different EU member states has generated sustained litigation across the EU. Additionally. Irish courts have addressed the tension between free movement of goods and pharmaceutical IP protection in a manner consistent with. but not identical to. approaches in Germany, the Netherlands, and France.
For an overview of the firm's practice in this area, see our intellectual property services in Ireland, which cover trademark registration, enforcement, and cross-border rights strategy.
Cross-border implications: post-Brexit complexity and the EEA perimeter
Brexit has materially altered the parallel import calculus for businesses trading between Ireland and the United Kingdom. Before the UK's departure from the EU, goods placed on the UK market were placed on the EEA market for exhaustion purposes. That is no longer the position.
Under current Irish and EU law, goods first placed on the UK market after the Brexit transition period ended are not exhausted in Ireland or anywhere else in the EEA. A rights holder can therefore invoke Irish IP rights to prevent those goods from entering Ireland from the UK. Even if the goods are genuine and even if the rights holder itself originally sold them in the UK. This represents a material change for distribution networks that historically treated the UK and Ireland as a single commercial territory.
The asymmetry runs in one direction only. The UK has adopted a unilateral approach that continues to treat EEA-first-placed goods as exhausted in the UK, at least for the transitional period. This creates a situation where goods sold by an Irish distributor into the UK can be re-imported into the UK market by parallel traders. However. Goods sold by a UK distributor into Ireland can be blocked at the border by the Irish rights holder. Businesses operating on both sides of the Irish Sea need to account for this asymmetry in their distribution contracts and IP enforcement strategies.
For European clients with operations in multiple EEA member states, Ireland's position as both an EU member state and an English common law jurisdiction makes it a strategically important venue for exhaustion disputes. The Irish courts' familiarity with both EU IP law and common law procedural tools. including interim injunctions, search orders. Additionally. Disclosure orders. means that Ireland can serve as an effective enforcement base for rights holders seeking to disrupt parallel import networks operating across multiple jurisdictions.
Irish courts have also addressed the interaction between exhaustion doctrine and parallel imports of goods bearing registered Community trademarks. Where the trademark in question is an EU trademark rather than a national Irish registration, the exhaustion analysis proceeds at the EU level. However. The procedural steps. filing, disclosure, interim relief. are taken in Irish courts applying Irish civil procedure. The substantive outcome tracks EU standards; the process reflects common law methodology.
Technology businesses operating in Ireland face an additional layer of complexity where IP rights intersect with software licensing and digital distribution. The distinction between a licensed product and a sold product is critical: exhaustion applies only to sales. A software product distributed under a subscription licence is not exhausted by the subscriber's act of use, because no sale of a copy has occurred. Businesses seeking to rely on licensing structures to avoid exhaustion must ensure that their agreements genuinely reflect a licence rather than a sale. Irish courts, like courts elsewhere in the EU, will examine the substance of the arrangement rather than its label.
The interplay between IP exhaustion and AI-driven distribution presents emerging challenges for rights holders in Ireland. Automated procurement platforms can identify price differentials across markets and execute cross-border purchases at a speed that makes traditional enforcement reactive rather than preventive. For businesses assessing how emerging technology affects their IP position, our analysis of AI law in Ireland addresses the regulatory and commercial dimensions of this intersection.
Strategic recommendations for rights holders and importers
Rights holders facing parallel import challenges in Ireland have several strategic levers available. The choice among them depends on the goods in question, the source of the imports, and the commercial objective. whether that is stopping the parallel trade entirely, managing it contractually, or neutralising its price impact.
The first lever is enforcement through Irish IP legislation. An infringement claim based on trademark rights, patent rights, or copyright is available where the goods were first placed on a market outside the EEA and no consent to EEA placement can be established. The rights holder must be prepared to trace the chain of title and to demonstrate the geographic origin of the first placement. This is fact-intensive and often requires disclosure applications in multiple jurisdictions.
The second lever is the legitimate reasons exception for trademark rights. Even where EEA exhaustion has technically occurred, a rights holder may be able to prevent further commercialisation if the goods have been repackaged. Relabelled. Alternatively, presented in a way that damages the trademark's function or reputation. This argument is most commonly deployed in pharmaceutical parallel trade cases, where repackaging is routine, but it has application wherever the goods' presentation has been materially altered from the rights holder's original specification.
A third lever is contractual. Distribution agreements should be structured to minimise the risk of unintended EEA placement. Tiered distribution arrangements, territorial restrictions with meaningful audit and compliance mechanisms. Additionally. Supply chain tracing obligations can reduce. though not eliminate. the risk that goods placed outside the EEA will be diverted into the EEA without the rights holder's knowledge. Irish law enforces such contractual arrangements, and breach by a distributor gives rise to both contractual and, in some circumstances, tortious claims alongside the IP enforcement action.
For importers and parallel traders, the central strategic question is whether consent to EEA placement can be established. If it can, the exhaustion defence is strong and the rights holder's claim fails. The challenge is that establishing consent requires documentary evidence of the supply chain, and that evidence is often in the hands of the rights holder or its authorised distributors. Importers who cannot trace the full provenance of their goods face significant legal exposure, particularly where the rights holder has registered trademarks and has already obtained surveillance or seizure orders at Irish customs.
Customs enforcement is an important practical dimension. Irish customs authorities can act on instructions from rights holders to detain suspected parallel imports at the border. The detention procedure requires the rights holder to demonstrate a prima facie IP right and a reasonable belief that the goods infringe that right. The importer then has a limited period to contest the detention. Rights holders who invest in proactive customs recordal – recording their IP rights with Irish Revenue's customs surveillance system – are significantly better positioned to intercept parallel imports before they enter the distribution network.
An opposition proceedings strategy can also be relevant where a parallel importer attempts to register a mark that is similar or identical to the rights holder's own trademark in order to establish a local commercial presence. Monitoring new trademark applications through the Intellectual Property Office of Ireland and filing oppositions where necessary forms part of a comprehensive parallel import defence strategy. The trademark application process in Ireland follows the Nice classification system, and rights holders should ensure their own registrations cover all relevant classes and goods descriptions before seeking to assert them against parallel importers.
For a comparative view of how exhaustion doctrine operates in a civil law jurisdiction adjacent to Ireland's trading relationships. Our analysis of parallel import and IP rights exhaustion in Portugal examines the doctrinal parallels and practical divergences relevant to cross-border rights strategy.
Outlook: regulatory trajectory and what to monitor
The regulatory environment governing parallel imports and IP exhaustion in Ireland is not static. Several developments are likely to affect how this area evolves over the next several years.
First, the EU's ongoing review of IP legislation – particularly in relation to the Trade Marks Directive and the design and patent exhaustion rules – may produce amendments that clarify or alter the consent analysis. Rights holders and importers operating in Ireland should monitor CJEU rulings on consent and authorisation, as those rulings bind Irish courts and can shift the outcome of pending disputes without any change to domestic legislation.
Second, the pharmaceutical sector is under sustained regulatory pressure to facilitate parallel trade within the EU as a mechanism for price convergence. The Irish market, as a small member state with relatively high pharmaceutical prices, is a regular destination for pharmaceutical parallel imports from lower-price member states. Regulatory guidance from the European Medicines Agency and from the Health Products Regulatory Authority in Ireland will shape how repackaging requirements and legitimate reasons exceptions are applied in this sector.
Third, the digital exhaustion question remains unresolved in significant areas. The CJEU's position that exhaustion does not apply to digital transmissions in the same way as physical sales creates ongoing commercial pressure in software, media, and platform markets. Legislative intervention at the EU level – whether through the Digital Markets Act or through sector-specific measures – may alter this position, with direct consequences for IP registration and licensing strategies in Ireland.
Fourth, customs enforcement tools are expected to be strengthened at the EU level, with enhanced digital surveillance of supply chains and greater coordination between member state customs authorities. Rights holders who invest now in customs recordal and supply chain monitoring will be well positioned to benefit from these tools as they become available.
Finally, the Irish courts' own jurisprudence on the legitimate reasons exception is developing. A series of cases involving repackaged goods. not all from the pharmaceutical sector. has given the Irish courts the opportunity to elaborate on what constitutes damage to a trademark's reputation or function in circumstances where the repackaging is minimal or where the trademark owner's own products are inconsistently presented across markets. Practitioners observe a gradual tightening of the threshold for the legitimate reasons exception, which narrows the window for rights holders seeking to prevent parallel trade on presentation grounds alone.
Rights holders who treat parallel import exposure as a compliance issue rather than a strategic one will find themselves consistently reactive. The businesses that manage this risk most effectively are those that combine proactive IP registration across all relevant classes and jurisdictions, robust supply chain contracts with meaningful audit rights. Active customs recordal. Additionally, a monitoring programme that detects parallel imports early enough to allow legal action before the parallel trader has established a market position. Engaging a lawyer ireland practitioners recommend for cross-border IP matters – one with experience in both Irish courts and EU regulatory proceedings – is a foundational element of that approach.
Frequently asked questions
Q: If goods are genuine and have not been tampered with, can an Irish court still issue an injunction to stop their sale?
A: Yes, in certain circumstances. Where the goods were first placed on a market outside the European Economic Area without the rights holder's consent to EEA distribution. The rights are not exhausted and an Irish court can grant interim or final injunctive relief. Even where EEA exhaustion has occurred, an injunction may be available if the legitimate reasons exception applies. for example. There. The goods have been repackaged in a way that damages the trademark's reputation or misleads consumers about the product's origin.
Q: How long does an IP infringement claim based on parallel imports typically take in Ireland?
A: The timeline varies considerably depending on whether the claim proceeds through interim relief applications or goes to full trial. An application for interim or interlocutory injunctive relief can be heard within weeks of filing, providing a fast-track mechanism to stop ongoing parallel imports while the substantive dispute is resolved. A full trial in the Commercial Court. which handles significant IP matters. typically runs from several months to well over a year depending on the complexity of the evidence and the volume of disclosure required. Rights holders should factor this timeline into their enforcement strategy and consider whether customs detention offers a faster practical remedy.
Q: Does Brexit mean that goods sold in the UK can no longer be freely imported into Ireland?
A: As a general rule, yes. Goods first placed on the UK market after the Brexit transition period ended are not exhausted in Ireland or elsewhere in the EEA. An Irish rights holder can therefore invoke IP rights to prevent those goods from entering Ireland from the UK. Even if the goods are genuine and the rights holder originally sold them into the UK market. This represents a significant change for businesses that historically operated Ireland and the UK as a single commercial zone. Additionally. It requires a review of distribution contracts and enforcement strategies for any business trading across the Irish Sea. Engaging a law firm ireland businesses trust for cross-border IP matters is a practical step to address this exposure.
About Ferraz & Whitmore
Ferraz & Whitmore is an international law firm based in Lisbon, advising business clients across 46 jurisdictions. Our intellectual property practice supports rights holders and market entrants in managing trademark registration, parallel import enforcement, and cross-border exhaustion disputes across European and international markets. As an international law firm in Ireland and across the EU, we combine Portuguese civil law expertise with English common law methodology to develop IP strategies that work across multiple legal systems simultaneously. Our team has advised on infringement claim proceedings, customs enforcement actions, and licensing disputes before Irish courts and EU regulatory bodies. The firm's IP practice spans 15 practice areas including trademark, patent, copyright, design rights, and technology regulation, with particular depth in matters that require coordinating rights strategy across both common law and civil law jurisdictions. To discuss how parallel import rules affect your business in Ireland, contact us at info@ferrazwhitmore.com.
Disclaimer: This publication is provided for informational purposes only and does not constitute legal advice. The information herein should not be relied upon as a substitute for professional legal counsel tailored to your specific circumstances. Ferraz & Whitmore assumes no liability for actions taken or not taken based on the contents of this material. For advice regarding your particular situation, please contact info@ferrazwhitmore.com.